Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A2NTX vs BOTOX for Post-Stroke Lower Limb Spasticity
NCT01910363Phase 3Unknown
- Sponsor
- Tokushima University
- Start
- Jul 2013
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of A2NTX in Spasticity, sponsored by Tokushima University. Status: unknown.
02
Drugs
A2NTX
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT01910363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910363.